Author

J. Norton

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Plant Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Organism:non-human primate· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:chicken / avian· 1

Frequent Co-Authors

G. Jensen· 2 shared G. Smith· 2 shared H. Zhou· 2 shared K. B. Gilbert· 2 shared K. Elliott· 2 shared K. M. Veley· 2 shared M. Guebre-Xabier· 2 shared M. Yoder· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPlant Biology

G. Jensen

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Clade-defining mutations in human H1N1 hemagglutinin protein from 2021-2023 have opposing effects on in vitro fitness and antigenic drift

N. J. Swanson, J. Girish, M. Yunker, H. Liu, J. Norton, C. Han, H. Mostafa, K. Fenstermacher, R. E. Rothman, A. Pekosz

This study identifies clade-defining mutations in H1N1 hemagglutinin that improve viral fitness but reduce neutralization by vaccine-induced antibodies, revealing an evolutionary trade-off between replication and immune evasion.

bioRxiv · May 18, 2024 · PreprintMicrobiology

XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants

N. Patel, J. F. Trost, M. Guebre-Xabier, H. Zhou, J. Norton, D. Jiang, Z. Cai, M. Zhu, A. M. Marchese, A. M. Greene, R. M. Mallory, R. Kalkeri, F. Dubovsky, G. Smith

This study shows that a monovalent XBB.1.5 spike protein vaccine induces broader neutralizing antibodies and stronger cellular immunity against multiple SARS-CoV-2 variants compared to bivalent vaccines.

bioRxiv · Aug 30, 2023Immunology

CRISPR/Cas9 generated MeSWEET10a mutants show reduced susceptibility to cassava bacterial blight and produce viable seed

K. Elliott, K. M. Veley, G. Jensen, K. B. Gilbert, J. Norton, L. Kambic, M. Yoder, A. Weil, S. Motomura-Wages, R. Bart

The paper uses CRISPR/Cas9 to edit MeSWEET10a in cassava, reducing susceptibility to bacterial blight without affecting seed viability.

bioRxiv · Jun 21, 2023 · PreprintPlant Biology

Improving cassava bacterial blight resistance by editing the epigenome

K. M. Veley, K. Elliott, G. Jensen, Z. Zhong, S. Feng, M. Yoder, K. B. Gilbert, J. C. Berry, Z.-J. D. Lin, B. Ghoshal, J. Gallego-Bartolome, J. Norton, S. Motomura-Wages, J. C. Carrington, S. E. Jacobsen, R. Bart

This study edits the epigenome of cassava to improve resistance to bacterial blight by blocking a susceptibility gene's activation.

bioRxiv · Jan 4, 2022Plant Biology

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice

J.-H. Tian, N. Patel, R. Haupt, H. Zhou, S. Weston, H. Hammond, J. Lague, A. D. Portnoff, J. Norton, M. Guebre-Xabier, B. Zhou, K. Jacobson, S. Maciejewski, R. Khatoon, M. Wisniewska, , G. Smith

This study evaluates the immunogenicity and protective efficacy of the NVX-CoV2373 SARS-CoV-2 vaccine in baboons and mice, showing strong immune responses and protection without enhanced disease.

bioRxiv · Jun 29, 2020Microbiology